141 related articles for article (PubMed ID: 38527847)
21. Prognostic significance of rituximab and radiotherapy for patients with primary mediastinal large B-cell lymphoma receiving doxorubicin-containing chemotherapy.
Xu LM; Fang H; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Ren H; Zhou LQ; Li YX
Leuk Lymphoma; 2013 Aug; 54(8):1684-90. PubMed ID: 23137070
[TBL] [Abstract][Full Text] [Related]
22. Treatment strategies and survival outcomes of primary mediastinal large B-cell lymphoma.
Quan L; He Z; Zuo X; Cao L; Wang Y; Dai H; Wu W; Shi X; Liu H
Hematology; 2023 Dec; 28(1):2217396. PubMed ID: 37260259
[TBL] [Abstract][Full Text] [Related]
23. Nivolumab Combined With Brentuximab Vedotin for Relapsed/Refractory Primary Mediastinal Large B-Cell Lymphoma: Efficacy and Safety From the Phase II CheckMate 436 Study.
Zinzani PL; Santoro A; Gritti G; Brice P; Barr PM; Kuruvilla J; Cunningham D; Kline J; Johnson NA; Mehta-Shah N; Manley T; Francis S; Sharma M; Moskowitz AJ
J Clin Oncol; 2019 Nov; 37(33):3081-3089. PubMed ID: 31398081
[TBL] [Abstract][Full Text] [Related]
24. Primary mediastinal large B-cell lymphoma.
Martelli M; Ferreri A; Di Rocco A; Ansuinelli M; Johnson PWM
Crit Rev Oncol Hematol; 2017 May; 113():318-327. PubMed ID: 28318892
[TBL] [Abstract][Full Text] [Related]
25. Primary Mediastinal Large B-Cell Lymphoma As an Incidental Finding: Report of a Case.
Yönal-Hindilerden İ; Hindilerden F; Arslan S; Doğan İÖ; Nalçacı M
Turk J Haematol; 2018 May; 35(2):141-142. PubMed ID: 27094863
[No Abstract] [Full Text] [Related]
26. Primary Mediastinal B-cell lymphoma with sclerosis: clinical and therapeutic evaluation of 22 patients.
Zinzani PL; Bendandi M; Frezza G; Gherlinzoni F; Merla E; Salvucci M; Magagnoli M; Babini L; Tura S
Leuk Lymphoma; 1996 Apr; 21(3-4):311-6. PubMed ID: 8726412
[TBL] [Abstract][Full Text] [Related]
27. Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.
Chan EHL; Koh LP; Lee J; De Mel S; Jeyasekharan A; Liu X; Tang T; Lim ST; Tao M; Quek R; Farid Bin Harunal Ras M; Lee YS; Diong C; Tan D; Kim SJ; Chee YL; Poon LMM
Cancer Med; 2019 Aug; 8(10):4626-4632. PubMed ID: 31264808
[TBL] [Abstract][Full Text] [Related]
28. Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.
Lisenko K; Dingeldein G; Cremer M; Kriegsmann M; Ho AD; Rieger M; Witzens-Harig M
BMC Cancer; 2017 May; 17(1):359. PubMed ID: 28532396
[TBL] [Abstract][Full Text] [Related]
29. Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma.
Ceriani L; Martelli M; Gospodarowicz MK; Ricardi U; Ferreri AJ; Chiappella A; Stelitano C; Balzarotti M; Cabrera ME; Cunningham D; Guarini A; Zinzani PL; Giovanella L; Johnson PW; Zucca E
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):42-49. PubMed ID: 27839910
[TBL] [Abstract][Full Text] [Related]
30. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
32. Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study.
Chiappella A; Casadei B; Chiusolo P; Di Rocco A; Ljevar S; Magni M; Angelillo P; Barbui AM; Cutini I; Dodero A; Bonifazi F; Tisi MC; Bramanti S; Musso M; Farina M; Martino M; Novo M; Grillo G; Patriarca F; Zacchi G; Krampera M; Pennisi M; Galli E; Martelli M; Ferreri AJM; Ferrari S; Saccardi R; Bermema A; Guidetti A; Miceli R; Zinzani PL; Corradini P
Leukemia; 2024 May; 38(5):1107-1114. PubMed ID: 38459167
[TBL] [Abstract][Full Text] [Related]
33. End of treatment FDG-PET in primary mediastinal B-cell lymphoma treated with R-chemotherapy: Prognostic indicator and implications for consolidation radiotherapy.
Freitas AC; Carvalho IP; Esteves S; Salgado L; Gomes da Silva M
Eur J Haematol; 2022 Feb; 108(2):118-124. PubMed ID: 34599779
[TBL] [Abstract][Full Text] [Related]
34. Brentuximab vedotin demonstrates an objective response in a patient with refractory CD30+ primary mediastinal B-cell lymphoma.
Badri N; Ngamdu KS; Torabi A; Guar S
J Cancer Res Ther; 2020; 16(1):183-185. PubMed ID: 32362635
[TBL] [Abstract][Full Text] [Related]
35. Primary Mediastinal B-Cell Lymphoma: Novel Precision Therapies and Future Directions.
Chen H; Pan T; He Y; Zeng R; Li Y; Yi L; Zang H; Chen S; Duan Q; Xiao L; Zhou H
Front Oncol; 2021; 11():654854. PubMed ID: 33869061
[TBL] [Abstract][Full Text] [Related]
36. Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach.
Hayden AR; Tonseth P; Lee DG; Villa D; Gerrie AS; Scott DW; Freeman CL; Slack GW; Farinha P; Skinnider B; Yenson PR; Benard F; Lo A; Pickles T; Wilson D; Connors JM; Sehn LH; Savage KJ
Blood; 2020 Dec; 136(24):2803-2811. PubMed ID: 32603413
[TBL] [Abstract][Full Text] [Related]
37. Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.
Oschlies I; Burkhardt B; Salaverria I; Rosenwald A; d'Amore ES; Szczepanowski M; Koch K; Hansmann ML; Stein H; Möller P; Reiter A; Zimmermann M; Rosolen A; Siebert R; Jaffe ES; Klapper W
Haematologica; 2011 Feb; 96(2):262-8. PubMed ID: 20971819
[TBL] [Abstract][Full Text] [Related]
38. Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma.
Lazarovici J; Terroir M; Arfi-Rouche J; Michot JM; Mussot S; Florea V; Ghigna MR; Dartigues P; Petrovanu C; Danu A; Fermé C; Ribrag V; Ghez D
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2018-2024. PubMed ID: 28634685
[TBL] [Abstract][Full Text] [Related]
39. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.
Rieger M; Österborg A; Pettengell R; White D; Gill D; Walewski J; Kuhnt E; Loeffler M; Pfreundschuh M; Ho AD;
Ann Oncol; 2011 Mar; 22(3):664-670. PubMed ID: 20724576
[TBL] [Abstract][Full Text] [Related]
40. [Eight-year experience in treating aggressive mediastinal large B-cell lymphomas].
Mangasarova IaK; Magomedova AU; Kravchenko SK; Shmakov RG; Bariakh EA; Vorob'ev VI; Mar'in DS; Skidan NI; Gemdzhian ÉG; Misiurin AV; Kremenetskaia AM; Vorob'ev AI
Ter Arkh; 2013; 85(7):50-6. PubMed ID: 24137947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
